A Real-World Analysis of TRK Inhibitor-Related Toxicities in Cancer Treatment - Supplementary material

Supplemntary Table S1. Characteristcs of included patients.Supplemnetary Table S2. Rank of adverse events.Table S3. Comparisons of the top 20 AEs between the FARES and USPI database.补充表S1. 纳入患者的特征。补充表S2. 不良事件（Adverse Events）的排名。表S3. FARES数据库与USPI数据库间前20项不良事件的对比分析。